tic criteria. The latest Ghent Nosology [Loeys et al., 2010] proposes a decision tree to assist diagnosis in which the focus has shifted from the musculoskeletal signs to the cardiovascular and ocular abnormalities.
Here, we report a patient who presented with ocular manifestations but minimal cardiac features. Genetic analysis revealed a mutation in the FBN1 gene, therefore, leading to the diagnosis of MFS.
Case Report
A 47-year-old female was referred to our hospital for evaluation. No skeletal (except pes planus), pulmonary or skin involvement was seen according to the old and the revised Ghent diagnostic criteria for MFS [De Paepe et al., 1996; Loeys et al., 2010] ( fig. 1 a-e) . From the ophthalmological point of view, the patient had a supero-temporal subluxation of both lenses in childhood. The right lens dislocated into the vitreous cavity favoring an openangle glaucoma; the left eye presented a total retinal detachment and secondary glaucoma after an ocular trauma that required enucleation later on. On examination, the right eye showed a thinned retina with peripapillar atrophy, a subretinal neovascular membrane and a posterior staphyloma in relation to her myopia, and aphakia with dislocation of the lens into the vitreous ( fig. 1 f) , requiring latanoprost treatment to reduce the intraocular pressure.
Cardiological examination revealed that the patient was asymptomatic, with no chest pain or syncope, and no murmurs in cardiac auscultation were heard. The 12-lead electrocardiogram revealed sinus rhythm with incomplete right bundle branch block and the echocardiogram showed mild dilatation of the ascending aorta (33 mm) and the aortic root (32 mm) (Z-score <2.0) [Roman et al., 1989] with no mitral valve prolapse. During the last 10 years, repeated echocardiograms have shown no changes in the aortic diameter.
Even though cardiac features were not significant, the eye phenotypes suggested sequencing of the FBN1 gene. After amplification of the patient's genomic DNA isolated from whole blood [Miller et al., 1988] , complete sequencing of all exons and flanking sequences revealed a novel variant at nucleotide 1583 of the transcript (ENST00000316623, c.1583G>T; Chr15; 48,805,751 G>T), leading to a nonsynonymous amino acid change (Cys to Phe) at position 538 of the FBN1 protein (ENSP00000325527, p.Cys538Phe) ( fig. 2 b) . This amino acid substitution affects one of the 6 highly conserved cysteines within one of the multiple calcium-binding epidermal growth factor-like domains (CaB-EGF; smart00179) of FBN1 ( fig. 2 c) .
Genetic screening within the family revealed that both the mother of the patient and one of the 2 sons were also carriers of the same mutation ( fig. 2 a) . The child affected by the mutation, a 14-year-old boy, developed supero-temporal subluxation of both lenses at the age of 4 years needing surgical correction, although intraocular pressure was within normal limits. Also, and as seen in his mother, no skeletal, skin (except for the presence of cutaneous abdominal striaes), pulmonary or aortic root dilatation (28 mm in diameter) were seen ( fig. 3 ). On the other hand, the mother of our patient only presented with myopia and cataracts with no evidence of significant aortic dilatation. Related family members 2.007, 2.004 and 2.006 presented with neither clinical presentations of Marfan syndrome nor carried the reported genetic variant at the FBN1 gene.
Discussion
Among a wide variety of phenotypic characteristics, ocular features are often seen in patients bearing FBN1 gene mutations. Myopia and astigmatism are the most common in MFS and often progress rapidly during childhood due to globe elongation and flat cornea, respectively [Nemet el al., 2006] . However, increased risk for retinal detachment secondary to the weakening of connective [Dietz, 2013] . In this study, a novel nonsynonymous amino acid change (Cys538Phe) affecting the sixth conserved cysteine (C6) of the CaB-EGF-like domain, encoded by exon 13 of the FBN1 gene, has been found. Previous studies have suggested that there is a correlation between ectopia lentis and cysteine substitutions in this type of domain [Schrijver et al., 1999] . Higher frequency and severity of disease symptoms occur when these substitutions affect either C1-C2 or C3-C4, suggesting that correct cysteine localization and disulfide bonding at these positions play an important role in the structural integrity of the suspensory ligaments of the lens [Nemet et al., 2006] . Our observations are in agreement with the view that mutations affecting the C5-C6 disulfide bond are not as severe, as we have identified carriers of the mutation with a mild MFS phenotype, even at the ocular level. The localization of the mutant CaB-EGF domain along the FBN1 polypeptide also appears to influence the severity of the phenotype observed. Cysteine substitutions in the vicinity of C538P on exon 13 (this study) such as C570R on exon 14 (previously 13) [Schrijver et al., 1999] , or C587Y on exon 15 (previously 14) [Booms et al., 1997] both result in ectopia lentis with some skeletal and integument features, but no cardiac symptoms. Likewise, more distant substitutions such as C776G [Katzke et al., 2002] , or C1782R [Adés et al., 2004] have been also shown to have little cardiac effect.
The great phenotypic variability observed in patients bearing FBN1 gene mutations imposes a diagnostic challenge. As we present in this study, even in a single family with the same mutation, the penetrance is highly variable in severity. According to the US National Marfan Foundation, the Ghent Nosology was revised [Loeys et al., 2010] , superseding the previous diagnostic criteria [De Paepe et al., 1996] . Currently, a decision tree assists in determining whether a patient has MFS or not, shifting the focus from the musculoskeletal signs to the cardiovascular and ocular abnormalities, so that the presence of a dilated aorta plus ectopia lentis is now sufficient to give an unequivocal diagnosis of MFS without the need of further genetic studies. For patients with either a dilated aorta or ectopia lentis, the presence of a causal FBN1 gene mutation is a crucial criterion for MFS [Summers et al., 2012] .
Furthermore, skeletal, skin, lung, facial, other ocular, and other cardiovascular signs have been included in a new scoring system in which a score of 7 points is associated with a diagnosis of MFS if there is either aortic dilatation and/or dissection, or a family history of the disease. In relation to the aortic diameter, dilatation of the aorta is determined at the sinus of Valsalva and ascending aorta, and measurements must be corrected for age and body size and compared with normative data using a Z-score calculation [Roman et al., 1989] .
In the absence of ectopia lentis, an FBN1 mutation and a family history of MFS, the diagnosis of MFS may only be made in the absence of discriminating features of Shprintzen-Goldberg syndrome, Loeys-Dietz syndrome and vascular Ehlers-Danlos syndrome. Also testing for genes encoding the transforming growth factor beta receptors (TGFBR2, TGFBR1) and collagen type III alpha 1 (COL3A1) mutations, and for abnormalities of collagen biochemistry should be ruled out [Summers et al., 2012] . In the case presented, ectopia lentis, accompanied by a FBN1 gene mutation and a mild nonprogressive aortic root dilatation/dissection lead to the diagnosis of MFS.
In this context, several studies have compared the old and the revised Ghent criteria in patient groups with suspected MFS and a known FBN1 mutation. However, and despite the high agreement level between both nosologies criteria, up to 10% of MFS patients were reclassified as ectopia lentis syndrome or MASS syndrome in the absence of aortic dilatation and, conversely, 5% were reclassified as MFS in the presence of aortic dilatation [Faivre et al., 2012] . This is the reason why some authors have criticized that the definition of aortic dilatation is based exclusively on aortic root Z-scores, which may underestimate aortic involvement [Radonic et al., 2011; Devereux et al., 2012] .
Since many patients carrying FBN1 mutations may develop classic MFS over time, genotype information is essential for the diagnosis or exclusion of MFS [Sheikhzadeh et al., 2012] , despite the fact that knowledge about a specific FBN1 mutation seems to have little prognostic value for an individual patient and cannot reliably guide individual management [Hoffjan, 2012] . In our case, although the FBN1 C538P mutation seems not to favor the progression of aortic root dilatation, periodic echocardiograms should be performed to prevent the risk of aortic dissection in the follow-up.
